A detailed history of Sargent Bickham Lagudis LLC transactions in Sanofi stock. As of the latest transaction made, Sargent Bickham Lagudis LLC holds 246 shares of SNY stock, worth $12,039. This represents 0.0% of its overall portfolio holdings.

Number of Shares
246
Previous 246 -0.0%
Holding current value
$12,039
Previous $9,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 13, 2022

BUY
$48.99 - $57.46 $12,051 - $14,135
246 New
246 $12,000
Q1 2020

Sep 07, 2021

SELL
$38.02 - $51.66 $3,763 - $5,114
-99 Closed
0 $0
Q4 2019

Sep 14, 2021

SELL
$44.25 - $50.86 $486 - $559
-11 Reduced 10.0%
99 $5,000
Q3 2019

Sep 14, 2021

BUY
$40.34 - $46.64 $403 - $466
10 Added 10.0%
110 $5,000
Q3 2018

Sep 13, 2021

BUY
$40.0 - $44.84 $4,000 - $4,484
100 New
100 $4,000
Q4 2016

Sep 13, 2021

SELL
N/A
-262 Closed
0 $0
Q3 2016

Sep 13, 2021

BUY
N/A
262
262 $10,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $123B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Sargent Bickham Lagudis LLC Portfolio

Follow Sargent Bickham Lagudis LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Bickham Lagudis LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Bickham Lagudis LLC with notifications on news.